Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling

Journal of Proteome Research

Volumn 12, Issue 1, 2013, Pages 505-512

  Zhang, Tao ^a,b   Wu, Xiaoyan ^a   Ke, Chaofu ^a   Yin, Mingzhu ^a   Li, Zhenzi ^a   Fan, Lijun ^a   Zhang, Wang ^a   Zhang, Haiyu ^a   Zhao, Falin ^c   Zhou, Xiaohua ^d   Lou, Ge ^a   Li, Kang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c HANGZHOU NORMAL UNIVERSITY   (China)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Biomarker; Epithelial ovarian cancer; Mass spectrometry; Metabolomics; Urine

Indexed keywords

HISTIDINE; MUCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METABOLOMICS; NUCLEOTIDE METABOLISM; OVARY CARCINOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUADRUPOLE MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TRYPTOPHAN METABOLISM; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

ADULT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MASS SPECTROMETRY; METABOLOMICS; OVARIAN NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINALYSIS;

EID: 84874067623     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3009572     Document Type: Article

References (48)

1. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010. Ca Cancer J. Clin. 2010, 60 (5), 277-300.
2. Jacobs, I. J.; Menon, U. Progress and challenges in screening for early detection of ovarian cancer. Mol. Cell Proteomics 2004, 3 (4), 355-66.
3. Sjovall, K.; Nilsson, B.; Einhorn, N. The significance of serum CA 125 elevation in malignant and nonmalignant diseases. Gynecol. Oncol. 2002, 85 (1), 175-8.
4. Van Calster, B.; Timmerman, D.; Bourne, T.; Testa, A. C.; Van Holsbeke, C.; Domali, E.; Jurkovic, D.; Neven, P.; Van Huffel, S.; Valentin, L. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. J. Natl. Cancer Inst. 2007, 99 (22), 1706-14.
5. Nicholson, J. K.; Lindon, J. C. Systems biology: Metabonomics. Nature 2008, 455 (7216), 1054-6.
6. Spratlin, J. L.; Serkova, N. J.; Eckhardt, S. G. Clinical applications of metabolomics in oncology: a review. Clin. Cancer Res. 2009, 15 (2), 431-40.
7. Claudino, W. M.; Quattrone, A.; Biganzoli, L.; Pestrin, M.; Bertini, I.; Di Leo, A. Metabolomics: available results, current research projects in breast cancer, and future applications. J. Clin. Oncol. 2007, 25 (19), 2840-6.
8. Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Zheng, X.; Xu, Y.; Ni, Y.; Zhao, A.; Xu, L. X.; Cai, S.; Jia, W. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J. Proteome Res. 2009, 8 (10), 4844-50.
9. Zhou, J.; Xu, B.; Huang, J.; Jia, X.; Xue, J.; Shi, X.; Xiao, L.; Li, W. 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma. Clin. Chim. Acta 2009, 401 (1-2), 8-13.
10. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457 (7231), 910-4.
11. Odunsi, K.; Wollman, R. M.; Ambrosone, C. B.; Hutson, A.; McCann, S. E.; Tammela, J.; Geisler, J. P.; Miller, G.; Sellers, T.; Cliby, W.; Qian, F.; Keitz, B.; Intengan, M.; Lele, S.; Alderfer, J. L. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int. J. Cancer 2005, 113 (5), 782-8.
12. Garcia, E.; Andrews, C.; Hua, J.; Kim, H. L.; Sukumaran, D. K.; Szyperski, T.; Odunsi, K. Diagnosis of early stage ovarian cancer by (1)h NMR metabonomics of serum explored by use of a microflow NMR probe. J. Proteome Res. 2011, 10 (4), 1765-71.
13. Chen, J.; Zhang, X.; Cao, R.; Lu, X.; Zhao, S.; Fekete, A.; Huang, Q.; Schmitt-Kopplin, P.; Wang, Y.; Xu, Z.; Wan, X.; Wu, X.; Zhao, N.; Xu, C.; Xu, G. Serum 27-nor-5beta-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer. J. Proteome Res. 2011, 10 (5), 2625-32.
14. Woo, H. M.; Kim, K. M.; Choi, M. H.; Jung, B. H.; Lee, J.; Kong, G.; Nam, S. J.; Kim, S.; Bai, S. W.; Chung, B. C. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin. Chim. Acta 2009, 400 (1-2), 63-9.
15. Guan, W.; Zhou, M.; Hampton, C. Y.; Benigno, B. B.; Walker, L. D.; Gray, A.; McDonald, J. F.; Fernandez, F. M. Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines. BMC Bioinf. 2009, 10, 259.
16. Slupsky, C. M.; Steed, H.; Wells, T. H.; Dabbs, K.; Schepansky, A.; Capstick, V.; Faught, W.; Sawyer, M. B. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers. Clin. Cancer Res. 2010, 16 (23), 5835-41.
17. Teneriello, M. G.; Park, R. C. Early detection of ovarian cancer. Ca Cancer J. Clin. 1995, 45 (2), 71-87.
18. Smith, C. A.; Want, E. J.; O'Maille, G.; Abagyan, R.; Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 2006, 78 (3), 779-87.
19. Smith, C. A. LC/MS Preprocessing and Analysis with xcms. Memory 2005, 1-13.
20. Tautenhahn, R.; Bottcher, C.; Neumann, S., Annotation of LC/ESI-MS Mass Signals. In Bioinformatics Research and Development; Hochreiter, S., Wagner, R., Eds.; Springer: Berlin/Heidelberg, 2007; Vol. 4414, pp 371-380.
21. Kuhl, C.; Tautenhahn, R.; Neumann, S. LC-MS Peak Annotation and Identification with CAMERA. 2010, October, 1-14 (http://www.bioconductor.org/ packages/release/bioc/vignettes/CAMERA/inst/doc/CAMERA.pdf).
22. Katajamaa, M.; Oresic, M. Data processing for mass spectrometrybased metabolomics. J. Chromatogr., A 2007, 1158 (1-2), 318-28.
23. van den Berg, R. A.; Hoefsloot, H. C.; Westerhuis, J. A.; Smilde, A. K.; van der Werf, M. J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 2006, 7, 142.
24. Sysi-Aho, M.; Katajamaa, M.; Yetukuri, L.; Oresic, M. Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinf. 2007, 8, 93.
25. Boulesteix, A. L.; Strimmer, K. Partial least squares: a versatile tool for the analysis of high-dimensional genomic data. Briefings Bioinf. 2007, 8 (1), 32-44.
26. Wiklund, S.; Nilsson, D.; Eriksson, L.; Sjostrom, M.; Wold, S.; Faber, K. A randomization test for PLS component selection. J. Chemom. 2007, 21 (10-11), 427-439.
27. Strimmer, K. fdrtool: a versatile R package for estimating local and tail area-based false discovery rates. Bioinformatics 2008, 24 (12), 1461-2.
28. R Development Core Team. R: A language and environment for statistical computing; R Foundation for Statistical Computing: Vienna, Austria, 2010; ISBN 3-900051-07-0.
29. Zhang, T.; Wu, X.; Yin, M.; Fan, L.; Zhang, H.; Zhao, F.; Zhang, W.; Ke, C.; Zhang, G.; Hou, Y.; Zhou, X.; Lou, G.; Li, K. Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry. Clin. Chim. Acta 2012, 413 (9-10), 861-868.
30. Medeiros, L. R.; Rosa, D. D.; da Rosa, M. I.; Bozzetti, M. C. Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009, 142 (2), 99-105.
31. Fong, M. Y.; McDunn, J.; Kakar, S. S. Identification of Metabolites in the Normal Ovary and Their Transformation in Primary and Metastatic Ovarian Cancer. PLoS One 2011, 6 (5), e19963.
32. Carrola, J.; Rocha, C. M.; Barros, A. S.; Gil, A. M.; Goodfellow, B. J.; Carreira, I. M.; Bernardo, J.; Gomes, A.; Sousa, V.; Carvalho, L.; Duarte, I. F. Metabolic signatures of lung cancer in biofluids: NMRbased metabonomics of urine. J. Proteome Res. 2011, 10 (1), 221-30.
33. Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Liu, Y.; Xu, Y.; Ni, Y.; Zhao, A.; Cai, S.; Xu, L. X.; Jia, W. Urinary metabonomic study on colorectal cancer. J. Proteome Res. 2010, 9 (3), 1627-34.
34. Chen, T.; Xie, G.; Wang, X.; Fan, J.; Qiu, Y.; Zheng, X.; Qi, X.; Cao, Y.; Su, M.; Xu, L. X.; Yen, Y.; Liu, P.; Jia, W. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol. Cell. Proteomics 2011, 10 (7), M110 004945.
35. Ben Sellem, D.; Elbayed, K.; Neuville, A.; Moussallieh, F. M.; Lang-Averous, G.; Piotto, M.; Bellocq, J. P.; Namer, I. J. Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR Spectroscopy. J. Oncol. 2011, 2011, 174019.
36. Deberardinis, R. J.; Sayed, N.; Ditsworth, D.; Thompson, C. B. Brick by brick: metabolism and tumor cell growth. Curr. Opin. Genet. Dev. 2008, 18 (1), 54-61.
37. Schram, K. H. Urinary nucleosides. Mass Spectrom. Rev. 1998, 17 (3), 131-251.
38. Borek, E. K. S., Atypical transfer RNA's and their origin in neoplastic cells. Adv. Cancer Res. 1972, 15 (163), 90.
39. Frolkis, A.; Knox, C.; Lim, E.; Jewison, T.; Law, V.; Hau, D. D.; Liu, P.; Gautam, B.; Ly, S.; Guo, A. C.; Xia, J.; Liang, Y.; Shrivastava, S.; Wishart, D. S. SMPDB: The Small Molecule Pathway Database. Nucleic Acids Res. 2010, 38 (Database issue), D480-7.
40. Arnaud, A.; Ramirez, M.; Baxter, J. H.; Angulo, A. J. Absorption of enterally administered N-acetyl-l-glutamine versus glutamine in pigs. Clin. Nutr. 2004, 23 (6), 1303-12.
41. Lopez-Pedrosa, J. M.; Manzano, M.; Baxter, J. H.; Rueda, R. Nacetyl-L-glutamine, a liquid-stable source of glutamine, partially prevents changes in body weight and on intestinal immunity induced by protein energy malnutrition in pigs. Dig. Dis. Sci. 2007, 52 (3), 650-8.
42. Sperner-Unterweger, B.; Neurauter, G.; Klieber, M.; Kurz, K.; Meraner, V.; Zeimet, A.; Fuchs, D. Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers. Immunobiology 2011, 216 (3), 296-301.
43. Gregory, S.; Kelly, N. D. Pantethine: a review of its biochemistry and therapeutic applications. Altern. Med. Rev. 1997, 2 (5), 365-377.
44. Hollingsworth, M. A.; Swanson, B. J. Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 2004, 4 (1), 45-60.
45. Stimpfl, M.; Schmid, B. C.; Schiebel, I.; Tong, D.; Leodolter, S.; Obermair, A.; Zeillinger, R. Expression of mucins and cytokeratins in ovarian cancer cell lines. Cancer Lett. 1999, 145 (1-2), 133-41.
46. Selak, M. A.; Armour, S. M.; MacKenzie, E. D.; Boulahbel, H.; Watson, D. G.; Mansfield, K. D.; Pan, Y.; Simon, M. C.; Thompson, C. B.; Gottlieb, E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005, 7 (1), 77-85.
47. Belenky, P.; Bogan, K. L.; Brenner, C. NAD+ metabolism in health and disease. Trends Biochem. Sci. 2007, 32 (1), 12-9.
48. Hsu, C. P.; Hariharan, N.; Alcendor, R. R.; Oka, S.; Sadoshima, J. Nicotinamide phosphoribosyltransferase regulates cell survival through autophagy in cardiomyocytes. Autophagy 2009, 5 (8), 1229-31.